ORBIMED ADVISORS LLC
10% Owner; Director; Director, 10% Owner · 19 filings · Latest: Aug 10, 2026
Adicet Bio, Inc.
BlossomHill Therapeutics, Inc.
Braveheart Bio, Inc.
Enliven Therapeutics, Inc.
ImageneBio, Inc.
Prelude Therapeutics Inc
Q32 Bio Inc.
Scribe Therapeutics, Inc.
Shattuck Labs, Inc.
Sionna Therapeutics, Inc.
Traws Pharma, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
PASG | OrbiMed Private Investments VII, LP | — | Jun 24, 2025 | Proposed Sale | $0.3516 | 1,076,120 | $378.4K | — | |
PASG | OrbiMed Private Investments VII, LP | — | Apr 15, 2025 | Proposed Sale | $0.383 | 787,179 | $301.5K | — | |
CMPX | OrbiMed Genesis Master Fund, L.P. | — | Apr 9, 2025 | Proposed Sale | $1.59 | 3,571,428 | $5.7M | — | |
IRON | OrbiMed Genesis Master Fund, L.P. | — | Mar 10, 2025 | Proposed Sale | $55.67 | 74,800 | $4.2M | — | |
IRON | OrbiMed Private Investments VI, LP | — | Mar 10, 2025 | Proposed Sale | $55.67 | 193,400 | $10.8M | — | |
IRON | OrbiMed Private Investments VIII, LP | — | Mar 10, 2025 | Proposed Sale | $55.67 | 299,200 | $16.7M | — | |
PASG | OrbiMed Private Investments VII, LP | — | Jan 6, 2025 | Proposed Sale | $0.829 | 1,140,740 | $945.7K | — | |
PASG | OrbiMed Private Investments VII, LP | — | Dec 4, 2024 | Proposed Sale | $0.89 | 2,985,518 | $2.7M | — | |
PASG | OrbiMed Private Investments VII, LP | — | Sep 16, 2024 | Proposed Sale | $0.807 | 927,572 | $748.6K | — |
← Previous
Page 3 of 3